COLL – collegium pharmaceutical, inc. (US:NASDAQ)
Stock Stats
News
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) [Yahoo! Finance]
Collegium Pharmaceutical (COLL) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $56.00 price target on the stock, up from $54.00.
Collegium Pharmaceutical (COLL) had its "buy" rating reaffirmed by HC Wainwright. They now have a $60.00 price target on the stock.
Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript [Seeking Alpha]
Collegium Pharmaceutical to Buy AZSTARYS for $650M, Expanding ADHD Franchise Through 2037 [Yahoo! Finance]
Form SCHEDULE 13G/A COLLEGIUM PHARMACEUTICAL Filed by: VANGUARD GROUP INC
Form 4 COLLEGIUM PHARMACEUTICAL For: Mar 18 Filed by: Dieter David
Form 8-K COLLEGIUM PHARMACEUTICAL For: Mar 19
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Dieter David
Form 4 COLLEGIUM PHARMACEUTICAL For: Mar 09 Filed by: Dieter David
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.